Earnings Call · Q3 FY2025·2025-10-28

Q3 25EPS -37.84%·Rev n/aQ2 25EPS -11.54%·Rev n/aQ1 25EPS -60.71%·Rev n/aQ4 24EPS -100.00%*·Rev n/a⚠ consensus missing

Kiniksa Pharmaceuticals International, plc KNSA

Jonathan Kirshenbaum — Investor Relations Officer

Sanj Patel — Chairman and Chief Executive Officer

Ross Moat — Commercial Leader or Head of Commercial Operations

Mark Ragosa — Chief Financial Officer

−2.9%1d on move date−3.1% vs SPY3d−8.2%5d−7.7%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more KNSA calls or request research access.

More KNSA calls Browse calls Request research access